Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeuroScience Associates (NSA) is a premier contract research organization (CRO) specializing in high-volume, high-quality neurohistology services for the pharmaceutical and biotechnology industries. Founded in 1989, the company is best known for its proprietary MultiBrain® and MultiSliver® technologies, which allow for the simultaneous processing of multiple tissue samples in a single block to ensure uniform staining and reduced variability. NSA provides a comprehensive suite of services including specialized staining, immunohistochemistry, digital imaging, and expert neuroanatomical analysis to support drug safety and efficacy studies. By streamlining the histological process, NSA enables researchers to accelerate their timelines while maintaining the rigorous standards required for regulatory submissions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeuroScience Associates.